Company Profile

Dr. Reddy's Laboratories Limited (NYSE: RDY)
12:40 PM EDT, 04/19/24
Last: $70.99 Change: +0.08 %Change: +0.11% Volume: 45,195
Detailed Quote
Open: $ 70.90   Volume: 45,195
High: $ 71.24   Yield(%) 0.58
Low: $ 70.72   P/E Ratio (ttm): 18.67
Dividend ($): 0.41   Market Cap ($): 11.81B
EPS ($) 3.80   Shares Out: 166.51M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -2.73
% Price Change (last 13 weeks): 4.05
% Price Change (last 26 weeks): 5.51
% Price Change (last 52 weeks): 18.86
% Price Change (year to date): 1.91
Management Effectiveness
Return on Equity (%): 21.06
Return on Assets (%): 14.41
Return on Invested Capital (%): 14.00
Profitability
Gross Profit Margin (%): 54.02
Net Profit Margin (%): 18.33
Operating Profit Margin (%): 21.24
Price & Volume
50-day Moving Average: $74.44
200-day Moving Average: $69.41
Avg. Daily Vol. (last 50 days): 182,997
Avg. Daily Vol. (last 200 days): 244,919
52-wk high: $77.72
52-wk low: $53.12
Bid: $70.94
Ask: $70.99
Company Information
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
Dr. Reddy's Laboratories Limited
Door No. 8-2-337 Road No. 3 Banjara Hills
Hyderabad TS 500034

Phone: 91.40.49002900
Fax: 91.40.49002999
http://www.drreddys.com
Per Share Data
Earnings (1year) ($): 3.80
Annual Dividend ($): 0.41
Current P/E Ratio (ttm): 18.67
Book Value ($): 16.88
Cash Flow ($): 4.31
Valuation Ratios
Price/Earnings (x): 18.67
Price/Sales (x): 3.10
Price/Book (x): 3.37
Price/Cash Flow (x): 13.17
Financial Strength
Quick Ratio (x): 1.84
Current Ratio (x): 2.41
LT Debt/Equity (x): 0.55
Total Debt/Equity (x): 5.83



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.